Patient Guide: Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax in Combination With Intravenous (IV) Obinutuzumab or Oral Ibrutinib in Adult Participants With Untreated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 20 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05105841
Status: COMPLETED
Condition: Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
Phase: PHASE2

Find a Study Location Near You

This study is available at 20 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Nagoya-shi, Aichi
  • Nagoya-shi, Aichi
  • Nagoya-shi, Aichi
  • • And 17 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily